BC
ARNA

Brookfield Corp’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Brookfield Corp’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,045
Closed -$2.62M – 773
2021
Q3 		$2.62M Buy
44,045
+4,122
+10% +$243K 0.01% 305
2021
Q2 		$2.72M Buy
39,923
+19,505
+96% +$1.27M 0.01% 306
2021
Q1 		$1.42M Buy
20,418
+6,053
+42% +$466K 0.01% 339
2020
Q4 		$1.1M Buy
14,365
+959
+7% +$71.9K ﹤0.01% 359
2020
Q3 		$1M Buy
13,406
+1,353
+11% +$90.2K 0.01% 301
2020
Q2 		$759K Buy
+12,053
New +$663K ﹤0.01% 301

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return